Back

Incidence, types, and predictors of AF recurrence after AF ablation with pulsed field ablation. A single-centre experience.

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Arrhythmias 11: atrial fibrillation Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Anna-Sophie Eberl

Medical University of Graz, Graz (Austria)

7 More presentations in this session

Presentation thumbnail
Focal pulsed field ablation in complex cases of atrial tachycardia - feasibility, outcome and safety of a novel technology
Doctor F. Bahlke (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Comparison of two DCCV algorithms - rational versus maximum fixed energy (PROTOCOLENERGY trial)
Doctor L. Rucki (Trinec, CZ)
Abstract Slides Video
Presentation thumbnail
One-year freedom from arrhythmia following radiofrequency ablation using proactive oesophageal cooling
Professor M. Gallagher (London, GB)
Abstract Slides Video
Presentation thumbnail
Impact of continuous positive airway pressure for severe sleep apnea on very late recurrence in patients receiving catheter ablation of atrial fibrillation
Doctor N. Tanaka (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Characterization and clinical significance of hemolysis after pulsed-field ablation for atrial fibrillation: insights from a multicentric analysis
Doctor M. Popa (Munich, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmias 11: atrial fibrillation

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Electrophysiological findings, incidence, and predictors for AF recurrence after pulsed field versus radiofrequency pulmonary vein isolation. A retrospective analysis.
thumbnail
Congress Presentation
Comparison of pulsed field ablation and thermal ablation for repeat procedures after failed prior thermal ablation for atrial fibrillation
thumbnail
Congress Presentation
Direct comparison of two commercially available pulsed field ablation systems for atrial fibrillation; procedure characteristics and acute outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources